Downloadable Slideset


Share

Program Content

Activities

  • Management of Nonmetastatic RCC
    Management of Nonmetastatic RCC at Initial Diagnosis
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 04, 2023

    View Activity
  • First-line Therapies in Advanced or Metastatic RCC
    First-line Therapies in Advanced or Metastatic RCC
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 04, 2023

    View Activity
  • Post Immune Checkpoint Inhibitor Therapy for RCC
    Post Immune Checkpoint Inhibitor Therapy for RCC: Second-line Therapy and Beyond
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 04, 2023

    View Activity

Faculty

cover img faculity

Katy Beckermann, MD, PhD

Assistant Professor
Department of Internal Medicine
Division of Hematology/Oncology
Vanderbilt University
Nashville, Tennessee

cover img faculity

Stephanie A. Berg, DO

Instructor of Medicine
Genitourinary Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Toni K. Choueiri, MD

Director, Lank Center for Genitourinary Oncology
Medical Director, International Strategic Initiatives
Dana-Farber Cancer Institute
Co-Leader, Kidney Cancer Program
Dana-Farber/Harvard Cancer Center
Jerome and Nancy Kohlberg Professor of Medicine
Harvard Medical School
Boston, Massachusetts 

Provided by

ProCE Banner

Supporters

Supported by educational grants from AVEO Pharmaceuticals, Inc. (“AVEO Oncology”) and Eisai. Supported by a medical education grant from Exelixis, Inc.

AVEO Pharmaceuticals, Inc.

Eisai

Exelixis, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner